FDA Clearance Tracker · P970051-S019
NUCLEUS 24 COCHLEAR IMPLANT SYSTEM
Last checked: Nov 20, 2026Latest source record: Mar 21, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Mar 21, 2002
Approved
Time to decision
149 days
Received Oct 23, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970051-S019
- Device name
- NUCLEUS 24 COCHLEAR IMPLANT SYSTEM
- Applicant
- Cochlear Americas
- Applicant location
- Lone Tree, CO
- Received
- Oct 23, 2001
- Decided
- Mar 21, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970051
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE SP-10 BEHIND-THE-EAR SPEECH PROCESSOR WITH ACE, CIS AND SPEAK SPEECH CODING STRATEGIES. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME ESPRIT3G AND IS INTENDED TO BE USED WITH THE CI24M, CI24R(ST) AND CI24R(CS) COCHLEAR IMPLANTS.
Source documents
Other decisions for Cochlear Americas
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260902 · Decided Jul 10, 2026 · 114 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.